KZA Media Thread, page-1311

A response on ST to a question of whether hospitals could be releasing data onto the ASX.
"Kazia will want clinicians (not hospitals) to present at a prestigious conference. AACR certainly qualifies as such. I highly doubt there will be any release of data prior to any actual abstract presentation in April. A second reason to have data released in U.S. (hopefully during trading hours) is that trading of KZA on the ASX has been unimpressive for the last 5-6 years, in response to news. There's more money in the U.S., more analysts, the hospitals where trials are ongoing are primarily in U.S., and not to slight any Australian researchers, more worldwide respect for the USDA clinical trial process than that of any other country."